Pfizer's stock (PFE) rose in the intraday levels, scoring a new profit of 0.46% in the last session, or 0.17 points, amid positive pressure from the 50-day SMA, with the dominance of the main upward short-term trend. 

Therefore we expect more gains for the stock, as long as it settles above 36.60, targeting the resistance of 39.43.